INDICATIONS     CONTRA-INDICATIONS     DOSAGE     SIDE-EFFECTS     PREGNANCY     OVERDOSE     IDENTIFICATION     PATIENT INFORMATION
STINGOSE : Lotion

SCHEDULING STATUS:
Not scheduled

PROPRIETARY NAME
(and dosage form)

STINGOSE : Lotion

COMPOSITION:
Aluminium sulphate 20% m/v

PHARMACOLOGICAL CLASSIFICATION:
A/13.4.2/Dermatological preparations. Other.

PHARMACOLOGICAL ACTION:
STINGOSE modifies protein and carbohydrates which are common components of biologically produced venoms.

INDICATIONS:
STINGOSE reduces the discomfort of bites and stings e.g. bees, sandflies, mosquitos and marine life.

CONTRA-INDICATIONS:
Hypersensitivity to aluminium sulphate.

WARNINGS:
Keep out of eyes. The seriousness of bites and stings must not be underestimated. STINGOSE does not protect against allergic reactions which may arise from bites or stings.
KEEP OUT OF REACH OF CHILDREN

DOSAGE AND DIRECTIONS FOR USE:
It is imperative that STINGOSE be applied immediately. Repeat as often as is necessary. Always take normal first aid precautions. Systemic manifestations are not affected. In serious cases seek medical advice. STINGOSE Lotion does not affect systemic venoms.

SIDE EFFECTS AND SPECIAL PRECAUTIONS:
Do not pre-treat area with alcohol or methylated spirits.

KNOWN SYMPTOMS OF OVERDOSAGE AND PARTICULARS OF ITS TREATMENT:
None.

IDENTIFICATION:
Clear to hazy, colourless to light grey solution.

PRESENTATION:
Presented in 25 mL bottle with handpump spray.

STORAGE INSTRUCTIONS:
Keep tightly closed to prevent drying out. Protect from light.

REGISTRATION NUMBER:
S/13.4.2/141

NAME AND BUSINESS ADDRESS OF APPLICANT:
THE BOOTS COMPANY (SOUTH AFRICA) (PTY) LTD.
Electron Avenue
ISANDO
1600

DATE OF PUBLICATION OF THIS PACKAGE INSERT:
August 1993
SAEPI HOME PAGE      TRADE NAME INDEX      GENERIC NAME INDEX      FEEDBACK
Information presented by Malahyde Information Systems © Copyright 1996-2000